veratridine has been researched along with Cerebral Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashton, D; Clincke, G; Marrannes, R; Van Reempts, J; Willems, R; Wynants, J | 1 |
| Arndts, D; Carano, RA; Fisher, M; Li, F; Meiler, MR; Pschorn, U; Sotak, CH; Takano, K; Tatlisumak, T | 1 |
2 other study(ies) available for veratridine and Cerebral Infarction
| Article | Year |
|---|---|
Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs.
Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Circulation; Extracellular Space; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Microelectrodes; Neuroprotective Agents; Piperidines; Pyramidal Cells; Sodium Channels; Thiazoles; Veratridine | 1997 |
Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.
Topics: Acetamides; Animals; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Cerebral Infarction; Ion Channels; Isoquinolines; Magnetic Resonance Imaging; Male; Neurons; Postmortem Changes; Rats; Rats, Sprague-Dawley; Veratridine | 2000 |